DJIA 17,156.85 24.88 0.15%
NASDAQ 4,562.19 9.43 0.21%
S&P 500 2,001.57 2.59 0.13%
market minute promo

Gilead Sciences (NASDAQ: GILD)

103.84 -0.92 (-0.88%)

REAL-TIME: Last trade at

company name or ticker

Recent Quotes

GILD $103.84 -0.88%
Company Photos
(Click to zoom)
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $104.57
Previous Close $104.76
Daily Range $101.90 - $105.79
52-Week Range $58.81 - $110.64
Market Cap $157.0B
P/E Ratio 23.59
Dividend (Yield) $0.00 (0.0%)
Volume 18,440,232
Average Daily Volume 14,119,380
Current FY EPS $7.26





Gilead Sciences (GILD) Description

Gilead Sciences created and sells the world’s top-selling HIV medications, Truvada and Atripla, and commands about 75% of the U.S. treatment market and more than 50% worldwide. Website:

News & Commentary

3 Reasons McKesson Corporation's Stock Could Rise

McKesson Corporation's stock continues to soar. Here's why the momentum just might keep going.

Merck Posts Positive Data on Osteoporosis Drug Odanacatib - Analyst Blog

Shire's Vyvanse Accepted for FDA Review for Binge Eating - Analyst Blog

Shire's Vyvanse Accepted for FDA Review for Binge Eating - Analyst Blog

3 Huge Stocks on Traders' Radars

The Gilead Sell Setup

A look at the charts indicates that this big biotech stock could break down in the near-term.

The Gilead Sell Setup

The Growing Problem For Income Investors

3 Hot Ways to Play the Biotechnology Bonanza

Could GlaxoSmithKline Be A Better Investment Than Gilead?

This Top Growth Fund Leans Heavily On Large-Cap Tech

Roche Starts Trials on Lampalizumab for Geographic Atrophy - Analyst Blog

See More GILD News...

GILD's Top Competitors

GILD $103.84 (-0.88%)
Current stock: GILD
AMGN $140.71 (0.99%)
Current stock: AMGN
CELG $92.26 (-0.33%)
Current stock: CELG
$0.00 (0.00%)
Current stock: